Trial site
Neuropsychiatrie s.r.o.
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease10 trials
- Mild cognitive impairment4 trials
- Lewy body dementia2 trials
- Schizophrenia1 trial
- Phase
- Phase 38 trials
- Phase 25 trials
- Status
- Completed6 trials
- Recruiting6 trials
- Active, not recruiting1 trial
- Lead sponsor
- Bristol-Myers Squibb3 trials
- ACADIA Pharmaceuticals Inc.2 trials
- Novo Nordisk A/S2 trials
- AriBio Co., Ltd.1 trial
- Inmune Bio, Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease4 recruiting
- Lewy body dementia2 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026